U.S., Sept. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07153835) titled 'Efficacy and Safety of Paliperidone in Schizophrenia - Bangladesh Study' on Aug. 16.
Brief Summary: This is a single-arm, open-label, multicenter, prospective quasi-experimental study evaluating the efficacy and safety of extended-release paliperidone in adults with schizophrenia in Bangladesh. The study will assess psychotic symptom improvement using the PANSS scale, monitor side effects using GASS, and evaluate quality of life via WHOQOL-BREF.
Study Start Date: Sept. 01
Study Type: INTERVENTIONAL
Condition:
Schizophrenia
Intervention:
DRUG: Paliperidone extended-release (ER)
Paliperidone extended-release (ER) tablets will b...